I
Immuron Limited D
D
IMRN
1.74000
USD
-0.12
(-6.45%)
مغلق
حجم التداول
5,335
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
9,967,827
الأخبار المقالات
العنوان: Immuron Limited
القطاع: Healthcare
الصناعة: Biotechnology
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.